CardioWear: A Wearable System for Ambulatory Cardiac Monitoring (aECG)

描述(由申请人提供)：轨道研究公司建议开发一种完全可穿戴的传感器，即称为HearoWear的动态心电监测设备，使其能够在基于家庭/门诊的条件下进行连续的心电生理监测。心脏穿戴将是一种可穿戴的服装设备，配备轨道研究公司的干式心电电极，长期监测心率和节律、心率变异性和心脏事件等心脏标记物。穿着舒适，易穿易脱，使用维护方便。平台线束在一定程度上是为NASA的应用程序开发的急性心电监测。ORI将使用定制设计的超低功耗机器对机器电子数据收发模块，将AECG数据上传到蜂窝网络(即Sprint的TeleHealth Solutions)，以连续分析、存储和显示记录的指标。云通信系统将允许对通过蜂窝门户收集和发送的心电数据进行实时检查和分析。该系统的预期用途是中到高风险患者，这些患者可以从出于疾病管理和预防医学原因而进行的持续监测中受益。总体而言，我们的目的是开发一种可穿戴平台，其性能优于传统的动态事件或Holter监测器，后者依赖胶带/凝胶电极。心脏穿戴的行业推动力包括目前的医疗保健计划，这些计划侧重于改善反应时间和为心脏病患者提供更好的护理。通过提高监测能力，MedicoWear将降低医疗成本、改善结果并拯救生命。 公共卫生相关性：有氧穿戴系统为目前相关的已建立的临床和技术需求提供了可行的解决方案，极大地限制了ACG研究。由此产生的Cardio Wear平台将提高患者的依从性，降低与疾病和治疗相关的成本，提高监测和诊断能力，所有这些都将改善患者的结局。关键词：动态心电图、动态心电图、电极、遥测、动态

DESCRIPTION (provided by applicant): Orbital Research proposes the development of a fully wearable sensor, ambulatory ECG monitoring device called CardioWear to enable continuous cardio- electrophysiology monitoring in home/ambulatory based conditions. CardioWear will be a wearable-garment device, equipped with Orbital Research dry ECG electrodes to monitor cardiac markers such as heart rate and rhythm, heart rate variability and cardiac events for long duration. CardioWear will be comfortable to wear, easy to don and doff, convenient to use and maintain. The platform harness has in part been developed for acute ECG monitoring for NASA applications. ORI will use a custom designed ultra-low power, machine to machine electronic data transceiver module to up-link aECG data to a cellular network (i.e Sprint's Telehealth Solutions) for continuous analysis, storage and display of the recorded metrics. The cloud communication system will allow real-time inspection and analysis of aECG data collected and sent through the cellular portal. The intended use of the system is for moderate-to-high risk patients that can benefit from continuous monitoring for both disease management and preventive medicine reasons. Overall, the intent is to develop a wearable platform that outperforms conventional ambulatory event or Holter monitors which depend on adhesive tape/gel-based electrodes. The industry driver for CardioWear includes current health care initiatives which are focused on improving response time and providing better care for cardiac patients. By improving monitoring capabilities, CardioWear will reduce health care costs, improve outcomes and save lives. PUBLIC HEALTH RELEVANCE: Cardio Wear system provides a feasible solution for the established clinical and technical needs currently associated, vastly limiting aECG studies. The resultant Cardio Wear platform will improve patient compliance, reduce disease and treatment related costs, advance monitoring and diagnostic capabilities, all these together will improve the outcomes for the patients. Keywords: aECG, Holter, electrode, telemetry, ambulatory